Allergy Diagnostics Market Expected to Hit US$ 4,000 Mn revenues by 2022-end

The global market for allergy diagnostics has been forecast to account for over US$ 4,000 Mn revenues by 2022-end, according to a latest research by Future Market Insights (FMI). The report further projects the market to exhibit an impressive CAGR of nearly 10% through 2022.

A key theory gaining popularity in the global allergy diagnostics market is “hygiene hypothesis”. According to the hypothesis, absence of exposure to microorganisms & infectious agents in early childhood is likely to increase proneness of individuals to allergies, refraining the essential development of their immune system. The urban and western lifestyles of people have made them more susceptible to allergic diseases, as they have limited exposure to infectious agents during their childhood.

Request for Table of Contents @ https://www.futuremarketinsights.com/toc/rep-gb-4959

Genetic factors and surging pollution levels are some major factors adding to the prevalence of allergic disorders. Introduction of advanced technologies and rapid growth in healthcare expenditure will play a major role in reducing impact of aforementioned factors. However, stricter government policies and regulations associated with drugs and therapies, and huge capital investment required for development of these drugs will remain as challenges for organisations operating in the market.

Several governments around the world are supporting development of vaccines and therapies associated with allergic diseases through investments in research and development activities related to allergy diagnostics. In addition, leading market players are focusing on revolutionizing and optimization of healthcare sector. A key strategy adopted by these players is collaboration with predominant organizations. For example – in 2016, Quest Diagnostics collaborated with AncestryDNA, in a bid to cater soaring demand from consumers for genetic tests, given the genetics’ role in development of allergies.

Request for Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4959

The surge in incidences of allergies such as asthma, allergic rhinitis, sinusitis, and food allergy, are driving demand for their diagnostics over the recent past. According to WHO, number of patients with asthma is likely to surpass 400 Mn by 2025-end. Moreover, statistics offered by American Academy of Allergy, Asthma, & Immunology depict around 15% of population worldwide to be suffering from allergic rhinitis worldwide annually.

FMI’s report has offered a list of key players that are actively operating in the allergy diagnostics market, which include Thermo Fisher Scientific, Inc., Siemens Healthcare, Danaher Corporation, Hitachi Chemical Co., Ltd., HOB Biotech Group Co, Biomérieux SA, Stallergenes Greer, R-Biopharm AG, Hycor Biomedical Inc., and Lincoln Diagnostics, Inc

Buy Allergy Diagnostics Market Report @ https://www.futuremarketinsights.com/checkout/4959

About Us – Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

CONTACT:

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

Email: sales@futuremarketinsights.com

Website: www.futuremarketinsights.com

This release was published on openPR.